Cargando…

Immunotherapy, Inflammation and Colorectal Cancer

Colorectal cancer (CRC) is the third most common cancer type, and third highest in mortality rates among cancer-related deaths in the United States. Originating from intestinal epithelial cells in the colon and rectum, that are impacted by numerous factors including genetics, environment and chronic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lichtenstern, Charles Robert, Ngu, Rachael Katie, Shalapour, Shabnam, Karin, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140520/ https://www.ncbi.nlm.nih.gov/pubmed/32143413 http://dx.doi.org/10.3390/cells9030618

Ejemplares similares

Regulation of antitumor immunity by inflammation-induced epigenetic alterations
por: Karin, Michael, et al.
Publicado: (2021)

Genetic and biological hallmarks of colorectal cancer
por: Li, Jiexi, et al.
Publicado: (2021)

Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 Receptor-insulin receptor substrate and STAT3 signaling
por: Sanchez-Lopez, Elsa, et al.
Publicado: (2015)

IRF1 regulates self-renewal and stress-responsiveness to support hematopoietic stem cell maintenance
por: Rundberg Nilsson, Alexandra, et al.
Publicado: (2023)

IRF1 regulates self-renewal and stress responsiveness to support hematopoietic stem cell maintenance
por: Rundberg Nilsson, Alexandra J. S., et al.
Publicado: (2023)

Immunotherapy for Colorectal Cancer
por: Boland, Patrick M., et al.
Publicado: (2017)

Exploring immunotherapy in colorectal cancer
por: Weng, Junyong, et al.
Publicado: (2022)

Combinatorial Immunotherapies for Metastatic Colorectal Cancer
por: Janssen, Eline, et al.
Publicado: (2020)

The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer
por: Chen, Shiu-Jau, et al.
Publicado: (2021)

Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015)

Emerging evidence of immunotherapy for colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2022)

Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
por: Carlsen, Lindsey, et al.
Publicado: (2022)

NK Cell-Based Immunotherapy in Colorectal Cancer
por: Della Chiesa, Mariella, et al.
Publicado: (2022)

Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
por: Aldahlawi, Alia M., et al.
Publicado: (2021)

Microbiota, Inflammation and Colorectal Cancer
por: Lucas, Cécily, et al.
Publicado: (2017)

Immunotherapy in Colorectal Cancer: Current and Future Strategies
por: Ooki, Akira, et al.
Publicado: (2021)

Neoadjuvant immunotherapy in primary and metastatic colorectal cancer
por: Kanani, A, et al.
Publicado: (2021)

Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
por: Yu, Xianzhe, et al.
Publicado: (2020)

Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
por: Rawla, Prashanth, et al.
Publicado: (2019)

Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
por: Nagayama, Satoshi, et al.
Publicado: (2021)

Immunotherapy in colorectal cancer: current achievements and future perspective
por: Fan, Ahui, et al.
Publicado: (2021)

The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Challenges and exploration for immunotherapies targeting cold colorectal cancer
por: Li, Dan-Dan, et al.
Publicado: (2023)

“Cold” colorectal cancer faces a bottleneck in immunotherapy
por: Liu, Jia-Liang, et al.
Publicado: (2023)

Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer
por: Heregger, Ronald, et al.
Publicado: (2023)

Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer
por: Ephraim, Ramya, et al.
Publicado: (2022)

IFNγ signaling integrity in colorectal cancer immunity and immunotherapy
por: Du, Wan, et al.
Publicado: (2021)

Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016)

Immunotherapy for Early Stage Colorectal Cancer: A Glance into the Future
por: Cohen, Romain, et al.
Publicado: (2020)

Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?
por: Fan, Jiaqiao, et al.
Publicado: (2018)

Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
por: Temraz, Sally, et al.
Publicado: (2019)

Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells
por: Gessani, Sandra, et al.
Publicado: (2019)

Immunotherapy-Related Publications in Colorectal Cancer: A Bibliometric Analysis
por: Sur, Daniel, et al.
Publicado: (2021)

Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy
por: Zheng, Wei, et al.
Publicado: (2022)

The Gut Microbiome, Microsatellite Status and the Response to Immunotherapy in Colorectal Cancer
por: Sillo, Toritseju O., et al.
Publicado: (2023)

Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
por: Zheng, Yue, et al.
Publicado: (2022)

Differential role of CXCR3 in inflammation and colorectal cancer
por: Abron, Jessicca D., et al.
Publicado: (2018)

Immunotherapy regimens for metastatic colorectal carcinomas
por: Bashir, Babar, et al.
Publicado: (2017)

The da Vinci Xi: a review of its capabilities, versatility, and potential role in robotic colorectal surgery
por: Ngu, James Chi-Yong, et al.
Publicado: (2017)

Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
por: Baraibar, Iosune, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6dtcpnnr84mrbmf4252sifjgd6